Skip to main content
. 2014 Jun 9;9(6):e99186. doi: 10.1371/journal.pone.0099186

Figure 3. Serum IGF-1 levels in different groups. (a) Serum levels of Lp(a) in patients with favorable outcomes and unfavorable outcomes; (b) Serum levels of Lp(a) in survivor and non- survivor.

Figure 3